Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
2011 · Aging · 686 citations
https://doi.org/10.18632/aging.100296
M
Melchiorre Cervello
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
195
Papers
10.0K
Citations
50
h-index
123
i10-index
Melchiorre Cervello is an academic researcher from National Research Council. The author has contributed to research in topics: PI3K/AKT/mTOR signaling in cancer & Cancer-related Molecular Pathways & Inflammatory mediators and NSAID effects. The author has an h-index of 50, co-authored 166 publications.
ORCID: 0000-0003-4923-7220Papers by this author
worksEffects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
2017 · Aging · 275 citations
https://doi.org/10.18632/aging.101250
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance
2016 · Cell Death and Disease · 140 citations
https://doi.org/10.1038/cddis.2016.175
Nanostructured Lipid Carriers-Containing Anticancer Compounds: Preparation, Characterization, and Cytotoxicity Studies
2007 · Drug Delivery · 72 citations
https://doi.org/10.1080/10717540600739914
Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy
2012 · Current Pharmaceutical Design · 44 citations
https://doi.org/10.2174/138161212799859701
Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
2014 · Journal of Nanobiotechnology · 26 citations
https://doi.org/10.1186/1477-3155-12-21
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat